Jove
Visualize
Contact Us

Related Experiment Videos

Toxic epidermal necrolysis.

Frederick A Pereira1, Adarsh Vijay Mudgil, David M Rosmarin

  • 1Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA. carozat@aol.com

Journal of the American Academy of Dermatology
|January 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine Inhibitor.

JAMA dermatology·2026
Same author

Utilization and predictors of use of immunomodulators for atopic dermatitis: A cohort study.

JAAD international·2026
Same author

Human papillomavirus vaccine uptake in ethnically diverse women living with systemic lupus erythematosus.

Lupus·2025
Same author

Prescription trends of antipsychotic medications in dermatology among Medicare patients, 2013-2020.

Dermatology online journal·2025
Same author

A Scalable Approach to Assess the Safety of Recently Marketed Systemic Treatments for Atopic Dermatitis in Clinical Practice: First Analysis Cycle of a Sequential Monitoring System.

The Journal of investigative dermatology·2024
Same author

Dermatological trends in emergency medicine.

The Journal of dermatological treatment·2020
Same journal

Hypoactive Sexual Desire Disorder in Menopausal Women: Dermatologic Implications of Antiandrogen and Testosterone Therapy.

Journal of the American Academy of Dermatology·2026
Same journal

Incise parallel, section perpendicular to the dermatoglyphs for diagnosis of acral melanocytic lesions-A comment on Thakker et al.

Journal of the American Academy of Dermatology·2026
Same journal

Response to Xue et al, "Defining super-responders is not the same as predicting rituximab response in pemphigus".

Journal of the American Academy of Dermatology·2026
Same journal

Comment on Nie et al. (2026) 'Suicidality Reports in Acne Patients Treated with Isotretinoin and Concomitant Antidepressants: A Descriptive Analysis of FDA Adverse Event Reporting System Data'.

Journal of the American Academy of Dermatology·2026
Same journal

Defining super-responders is not the same as predicting rituximab response in pemphigus.

Journal of the American Academy of Dermatology·2026
Same journal

Eosinophilic fasciitis induced by checkpoint inhibitors: a retrospective multicenter case-series, comparison with eosinophilic fasciitis unrelated to checkpoint inhibition and literature review.

Journal of the American Academy of Dermatology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Toxic epidermal necrolysis (TEN), a severe drug reaction, involves keratinocyte apoptosis and T-cell pathways. Current treatment strategies lack definitive evidence, highlighting the need for further research into this rare, life-threatening condition.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Toxic epidermal necrolysis (TEN) is a severe, unpredictable drug reaction with high mortality.
  • The condition is characterized by massive keratinocyte apoptosis.
  • Cytotoxic T lymphocytes are implicated as effector cells, involving Fas-ligand and perforin/granzyme pathways.

Purpose of the Study:

  • To review current understanding of TEN's classification, presentation, etiology, pathophysiology, prognosis, and treatment.
  • To discuss the controversies and limitations in current therapeutic approaches for TEN.
  • To highlight the challenges in TEN research, including rarity and lack of animal models.

Main Methods:

  • Review of recent clinical data on TEN.
  • Analysis of experimental evidence regarding TEN pathogenesis.

Related Experiment Videos

  • Synthesis of information on various treatment modalities and their supporting/contradictory evidence.

    • Main Results:

    • Clinical data on TEN is largely anecdotal or from observational/retrospective studies.
    • Evidence for and against treatments like IVIG and corticosteroids is conflicting.
    • Optimal treatment strategies for TEN remain unclear, with combination therapies suggested but not proven.

    Conclusions:

    • Definitive answers regarding TEN treatment are not yet available.
    • Placebo-controlled trials are difficult due to TEN's rarity.
    • Further research is crucial to establish effective management for TEN.